Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (IDXX)
NASDAQ:IDXX
Idexx Laboratories (IDXX) Stock Price & Analysis
1,893 Followers
IDXX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$372.50 - $583.39
Previous Close$543.45
Volume445.98K
Average Volume (3M)443.60K
Market Cap
$44.88B
Enterprise Value$45.67B
Total Cash (Recent Filing)$331.70M
Total Debt (Recent Filing)$1.12B
Price to Earnings (P/E)52.7
Beta1.44
Next Earnings
Aug 06, 2024EPS Estimate
$2.89Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.32
Shares Outstanding82,587,328
10 Day Avg. Volume524,982
30 Day Avg. Volume443,603
Standard Deviation0.10
R-Squared0.45
Alpha0.00444
Financial Highlights & Ratios
Price to Book (P/B)41.62
Price to Sales (P/S)53.92
Price to Cash Flow (P/CF)43.10
P/FCF Ratio41.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue12.73
Enterprise Value/Gross Profit16.85
Enterprise Value/Ebitda38.24
Forecast
1Y Price Target
$580.17Price Target Upside6.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Idexx Laboratories News
PremiumCompany Announcements
IDEXX Laboratories Sees Leadership Transition and Shareholder Approval
PremiumPre-Earnings
Is IDXX a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe higher gross margin more than offset the softer revenue, showing the company’s ability to manage profitability amid revenue challenges.
Industry TrendsAnalysts anticipate veterinary visits to improve, supporting a flat visit growth rate for the year.
Product LaunchThe company remains on track for the launch of the InVue Dx analyzer which could begin to contribute in 2025.
Bears Say
Earnings ImpactIDEXX Labs' leverage to visit volumes creates a difficult setup for the company's upcoming quarterly financial results.
Financial GuidanceIDEXX reported slightly lower 1Q24 CAG Dx recurring revenue and reduced its 2024 CAG Dx recurring revenue guidance.
Veterinary Visit TrendsApril vet visits were softer compared to March, indicating a potential ongoing decrease in customer engagement.
---
Ownership Overview
1.54% Insiders
28.86% Mutual Funds
47.19% Other Institutional Investors
22.41% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IDXX FAQ
What was Idexx Laboratories’s price range in the past 12 months?
Idexx Laboratories lowest stock price was $372.50 and its highest was $583.39 in the past 12 months.
What is Idexx Laboratories’s market cap?
Currently, no data Available
When is Idexx Laboratories’s upcoming earnings report date?
Idexx Laboratories’s upcoming earnings report date is Aug 06, 2024 which is in 80 days.
How were Idexx Laboratories’s earnings last quarter?
Idexx Laboratories released its earnings results on May 01, 2024. The company reported $2.81 earnings per share for the quarter, beating the consensus estimate of $2.712 by $0.098.
Is Idexx Laboratories overvalued?
According to Wall Street analysts Idexx Laboratories’s price is currently Undervalued.
Does Idexx Laboratories pay dividends?
Idexx Laboratories does not currently pay dividends.
What is Idexx Laboratories’s EPS estimate?
Idexx Laboratories’s EPS estimate is $2.89.
How many shares outstanding does Idexx Laboratories have?
Idexx Laboratories has 82,587,326 shares outstanding.
What happened to Idexx Laboratories’s price movement after its last earnings report?
Idexx Laboratories reported an EPS of $2.81 in its last earnings report, beating expectations of $2.712. Following the earnings report the stock price went down -5.017%.
Which hedge fund is a major shareholder of Idexx Laboratories?
Among the largest hedge funds holding Idexx Laboratories’s share is Spence Asset Management. It holds Idexx Laboratories’s shares valued at 23M.
---
Idexx Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$580.17 (6.76% Upside)
$580.17 (6.76% Upside)
Blogger Sentiment
Bullish
IDXX Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 83.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.56%
12-Months-Change
Fundamentals
Return on Equity
71.91%
Trailing 12-Months
Asset Growth
19.41%
Trailing 12-Months
Company Description
Idexx Laboratories
Maine-based IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.
---
IDXX Earnings Call
Q1 2024
0:00 / 0:00
---
IDXX Revenue Breakdown
34.93% Reference laboratory diagnostic and consulting services
32.46% IDEXX VetLab consumables
9.41% Rapid assay products
7.63% Veterinary software, services and diagnostic imaging systems
15.58% Other
---
IDXX Stock 12 Month Forecast
Average Price Target
$580.17
▲(6.76% Upside)
Technical Analysis
Best Analysts Covering IDXX
1 Year
1 Year Success Rate
14/17 ratings generated profit
1 Year Average Return
+23.04%
reiterated a buy rating 5 days ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +23.04% per trade.
---